Some may disagree with me I'm sure. I personally think that due to fundamentals, $1 is a bit of a stretch with their current O/S.
I don't think a market cap nearing $1 Billion would be justified. Just my own personal opinion I think $100 million could be warranted depending if the are seeing $20-$50 million in sales.
However, I will say, I have seen companies that have virtually no assets or revenue reach obscene valuations. So literally anything is possible.
Difference here is ARYC is a real company, that is selling real products in the BioTech space.